NM_001306089.2:c.5113-202C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001306089.2(ZNF236):c.5113-202C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.493 in 152,012 control chromosomes in the GnomAD database, including 20,326 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.49 ( 20326 hom., cov: 32)
Consequence
ZNF236
NM_001306089.2 intron
NM_001306089.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.108
Publications
6 publications found
Genes affected
ZNF236 (HGNC:13028): (zinc finger protein 236) Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in cellular response to glucose stimulus. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.602 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ZNF236 | ENST00000320610.14 | c.5113-202C>T | intron_variant | Intron 28 of 30 | 1 | NM_001306089.2 | ENSP00000322361.9 | |||
| ZNF236 | ENST00000253159.12 | c.5107-202C>T | intron_variant | Intron 28 of 30 | 1 | ENSP00000253159.8 | ||||
| ZNF236 | ENST00000543926.6 | n.*512-202C>T | intron_variant | Intron 29 of 31 | 1 | ENSP00000444524.2 |
Frequencies
GnomAD3 genomes AF: 0.493 AC: 74915AN: 151894Hom.: 20321 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
74915
AN:
151894
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.493 AC: 74934AN: 152012Hom.: 20326 Cov.: 32 AF XY: 0.493 AC XY: 36599AN XY: 74296 show subpopulations
GnomAD4 genome
AF:
AC:
74934
AN:
152012
Hom.:
Cov.:
32
AF XY:
AC XY:
36599
AN XY:
74296
show subpopulations
African (AFR)
AF:
AC:
10475
AN:
41478
American (AMR)
AF:
AC:
8156
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
1836
AN:
3470
East Asian (EAS)
AF:
AC:
2658
AN:
5166
South Asian (SAS)
AF:
AC:
2535
AN:
4802
European-Finnish (FIN)
AF:
AC:
6356
AN:
10564
Middle Eastern (MID)
AF:
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
AC:
41211
AN:
67926
Other (OTH)
AF:
AC:
1087
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1793
3585
5378
7170
8963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
666
1332
1998
2664
3330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1588
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.